קרדיולוגיהבעריכת ד"ר מנחם נהיר

New Diagnostic Criteria for Familial Combined Hyperlipidemia Proposed

NEW YORK (Reuters Health) Mar 01 – Apolipoprotein B (apoB) and small dense low-density lipoprotein (LDL) appear to be a better way to define familial combined hyperlipidemia (FCH) than current criteria, Dutch investigators suggest.
"FCH is characterized by a variable expression of hypercholesterolemia and/or hypertriglyceridemia," Dr. Mario J. Veerkamp and colleagues, from the University Medical Center Nijmegen, note in the February issue of Arteriosclerosis, Thrombosis, and Vascular Biology: Journal of the American Heart Association.

The researchers examined variability in lipid phenotype expression over a 5-year period in subjects from 32 families classified as having FCH based on total cholesterol and/or triglyceride levels exceeding the 90th percentile after adjustment for age and sex.

At the start of the study, 93 (31%) of the subjects were affected and 206 (69%) were unaffected relatives. Five years later, "a diagnosis of FCH was consistent in 69 (74%) of the 93 subjects," the team reports. Hence, 26% of the FCH subjects showed a sporadic normolipidemic pattern.

Among the 206 unaffected relatives at the start of the study, 28 (14%) developed an FCH lipid phenotype over 5 years. …

לכתבה המלאה

0 תגובות

השאירו תגובה

רוצה להצטרף לדיון?
תרגישו חופשי לתרום!

כתיבת תגובה

מידע נוסף לעיונך

כתבות בנושאים דומים

© ‫ e-Med
 כל הזכויות שמורות

 

התכנים המוצגים באתר זה מיועדים לאנשי צוות רפואי בלבד

אם כבר נרשמת, יש להקליד את פרטי הזיהוי שלך
עדיין לא נרשמת? באפשרותך לבצע רישום כאן
להרשמה לאתר